FDA Approves First Treatment for Rare Brain Disorder Alexander Disease
Source Summary
The FDA approved zilganersen (Zanvastro), an antisense oligonucleotide, as the first treatment for Alexander disease in pediatric and adult patients. The approval was announced Thursday by the agency.
Why it matters
This is the first FDA-approved treatment for Alexander disease, a rare brain disorder that previously had no approved therapeutic options.
